Literature DB >> 26196325

Restricted replication of the live attenuated influenza A virus vaccine during infection of primary differentiated human nasal epithelial cells.

William A Fischer1, Landon S King2, Andrew P Lane3, Andrew Pekosz4.   

Abstract

Live Attenuated Influenza Vaccine (LAIV) strains are associated with cold adapted, temperature sensitive and attenuated phenotypes that have been studied in non-human or immortalized cell cultures as well as in animal models. Using a primary, differentiated human nasal epithelial cell (hNEC) culture system we compared the replication kinetics, levels of cell-associated viral proteins and virus particle release during infection with LAIV or the corresponding wild type (WT) influenza viruses. At both 33 °C and 37 °C, seasonal influenza virus and an antigenically matched LAIV replicated to similar titers in MDCK cells but seasonal influenza virus replicated to higher titers than LAIV in hNEC cultures, suggesting a greater restriction of LAIV replication in hNEC cultures. Despite the disparity in infectious virus production, the supernatants from H1N1 and LAIV infected hNEC cultures had equivalent amounts of viral proteins and hemagglutination titers, suggesting the formation of non-infectious virus particles by LAIV in hNEC cultures.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Influenza; Live attenuated influenza vaccine; Nasal epithelial cells

Mesh:

Substances:

Year:  2015        PMID: 26196325      PMCID: PMC4547880          DOI: 10.1016/j.vaccine.2015.07.023

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  31 in total

Review 1.  Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines.

Authors:  Brian R Murphy; Kathleen Coelingh
Journal:  Viral Immunol       Date:  2002       Impact factor: 2.257

2.  Adaptation and growth characteristics of influenza virus at 25 degrees c.

Authors:  H F Maassab
Journal:  Nature       Date:  1967-02-11       Impact factor: 49.962

3.  Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60.

Authors:  Hong Jin; Bin Lu; Helen Zhou; Chienhui Ma; Jackie Zhao; Chin-fen Yang; George Kemble; Harry Greenberg
Journal:  Virology       Date:  2003-02-01       Impact factor: 3.616

4.  The cholesterol recognition/interaction amino acid consensus motif of the influenza A virus M2 protein is not required for virus replication but contributes to virulence.

Authors:  Shaun M Stewart; Wai-Hong Wu; Erin N Lalime; Andrew Pekosz
Journal:  Virology       Date:  2010-07-24       Impact factor: 3.616

5.  Live attenuated influenza vaccine strains elicit a greater innate immune response than antigenically-matched seasonal influenza viruses during infection of human nasal epithelial cell cultures.

Authors:  William A Fischer; Kelly D Chason; Missy Brighton; Ilona Jaspers
Journal:  Vaccine       Date:  2014-01-30       Impact factor: 3.641

6.  Elevation of nasal viral levels by suppression of fever in ferrets infected with influenza viruses of differing virulence.

Authors:  R H Husseini; C Sweet; M H Collie; H Smith
Journal:  J Infect Dis       Date:  1982-04       Impact factor: 5.226

7.  mRNA for genes associated with antigen presentation are expressed by human middle meatal epithelial cells in culture.

Authors:  Andrew P Lane; Bahman Saatian; Xiao-Ying Yu; Ernst William Spannhake
Journal:  Laryngoscope       Date:  2004-10       Impact factor: 3.325

8.  Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004.

Authors:  M Elizabeth Halloran; Pedro A Piedra; Ira M Longini; Manjusha J Gaglani; Brian Schmotzer; Charles Fewlass; Gayla B Herschler; W Paul Glezen
Journal:  Vaccine       Date:  2007-03-12       Impact factor: 3.641

9.  Expression of influenza A virus internal antigens on the surface of infected P815 cells.

Authors:  J W Yewdell; E Frank; W Gerhard
Journal:  J Immunol       Date:  1981-05       Impact factor: 5.422

10.  Comparative study of influenza virus replication in MDCK cells and in primary cells derived from adenoids and airway epithelium.

Authors:  Natalia A Ilyushina; Mine R Ikizler; Yoshihiro Kawaoka; Larisa G Rudenko; John J Treanor; Kanta Subbarao; Peter F Wright
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

View more
  13 in total

1.  Influenza A Virus M2 Protein Apical Targeting Is Required for Efficient Virus Replication.

Authors:  Nicholas Wohlgemuth; Andrew P Lane; Andrew Pekosz
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

2.  H5N2 vaccine viruses on Russian and US live attenuated influenza virus backbones demonstrate similar infectivity, immunogenicity and protection in ferrets.

Authors:  Rita Czakó; Leatrice Vogel; Troy Sutton; Yumiko Matsuoka; Florian Krammer; Zhongying Chen; Hong Jin; Kanta Subbarao
Journal:  Vaccine       Date:  2018-03-01       Impact factor: 3.641

3.  Estrogenic compounds reduce influenza A virus replication in primary human nasal epithelial cells derived from female, but not male, donors.

Authors:  Jackye Peretz; Andrew Pekosz; Andrew P Lane; Sabra L Klein
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-12-18       Impact factor: 5.464

4.  The M2 protein of live, attenuated influenza vaccine encodes a mutation that reduces replication in human nasal epithelial cells.

Authors:  Nicholas Wohlgemuth; Yang Ye; Katherine J Fenstermacher; Hsuan Liu; Andrew P Lane; Andrew Pekosz
Journal:  Vaccine       Date:  2017-10-25       Impact factor: 3.641

5.  Evaluation of the innate immune responses to influenza and live-attenuated influenza vaccine infection in primary differentiated human nasal epithelial cells.

Authors:  Adriana Forero; Katherine Fenstermacher; Nicholas Wohlgemuth; Andrew Nishida; Victoria Carter; Elise A Smith; Xinxia Peng; Melissa Hayes; Doreen Francis; John Treanor; Juliet Morrison; Sabra L Klein; Andrew Lane; Michael G Katze; Andrew Pekosz
Journal:  Vaccine       Date:  2017-09-28       Impact factor: 3.641

6.  Changes in sialic acid binding associated with egg adaptation decrease live attenuated influenza virus replication in human nasal epithelial cell cultures.

Authors:  Harrison Powell; Hsuan Liu; Andrew Pekosz
Journal:  Vaccine       Date:  2021-05-11       Impact factor: 4.169

7.  Stability of the Influenza Virus Hemagglutinin Protein Correlates with Evolutionary Dynamics.

Authors:  Eili Y Klein; Deena Blumenkrantz; Adrian Serohijos; Eugene Shakhnovich; Jeong-Mo Choi; João V Rodrigues; Brendan D Smith; Andrew P Lane; Andrew Feldman; Andrew Pekosz
Journal:  mSphere       Date:  2018-01-03       Impact factor: 4.389

8.  Neuraminidase antigenic drift of H3N2 clade 3c.2a viruses alters virus replication, enzymatic activity and inhibitory antibody binding.

Authors:  Harrison Powell; Andrew Pekosz
Journal:  PLoS Pathog       Date:  2020-06-29       Impact factor: 6.823

9.  Characterizing Emerging Canine H3 Influenza Viruses.

Authors:  Luis Martinez-Sobrido; Pilar Blanco-Lobo; Laura Rodriguez; Theresa Fitzgerald; Hanyuan Zhang; Phuong Nguyen; Christopher S Anderson; Jeanne Holden-Wiltse; Sanjukta Bandyopadhyay; Aitor Nogales; Marta L DeDiego; Brian R Wasik; Benjamin L Miller; Carole Henry; Patrick C Wilson; Mark Y Sangster; John J Treanor; David J Topham; Lauren Byrd-Leotis; David A Steinhauer; Richard D Cummings; Jasmina M Luczo; Stephen M Tompkins; Kaori Sakamoto; Cheryl A Jones; John Steel; Anice C Lowen; Shamika Danzy; Hui Tao; Ashley L Fink; Sabra L Klein; Nicholas Wohlgemuth; Katherine J Fenstermacher; Farah El Najjar; Andrew Pekosz; Lauren Sauer; Mitra K Lewis; Kathryn Shaw-Saliba; Richard E Rothman; Zhen-Ying Liu; Kuan-Fu Chen; Colin R Parrish; Ian E H Voorhees; Yoshihiro Kawaoka; Gabriele Neumann; Shiho Chiba; Shufang Fan; Masato Hatta; Huihui Kong; Gongxun Zhong; Guojun Wang; Melissa B Uccellini; Adolfo García-Sastre; Daniel R Perez; Lucas M Ferreri; Sander Herfst; Mathilde Richard; Ron Fouchier; David Burke; David Pattinson; Derek J Smith; Victoria Meliopoulos; Pamela Freiden; Brandi Livingston; Bridgett Sharp; Sean Cherry; Juan Carlos Dib; Guohua Yang; Charles J Russell; Subrata Barman; Richard J Webby; Scott Krauss; Angela Danner; Karlie Woodard; Malik Peiris; R A P M Perera; M C W Chan; Elena A Govorkova; Bindumadhav M Marathe; Philippe N Q Pascua; Gavin Smith; Yao-Tsun Li; Paul G Thomas; Stacey Schultz-Cherry
Journal:  PLoS Pathog       Date:  2020-04-14       Impact factor: 6.823

10.  Identification of H3N2 NA and PB1-F2 genetic variants and their association with disease symptoms during the 2014-15 influenza season.

Authors:  Deena R Blumenkrantz; Thomas Mehoke; Kathryn Shaw-Saliba; Harrison Powell; Nicholas Wohlgemuth; Hsuan Liu; Elizabeth Macias; Jared Evans; Mitra Lewis; Rebecca Medina; Justin Hardick; Lauren M Sauer; Andrea Dugas; Anna DuVal; Andrew P Lane; Charlotte Gaydos; Richard Rothman; Peter Thielen; Andrew Pekosz
Journal:  Virus Evol       Date:  2021-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.